Welcome to our dedicated page for Coretec Group news (Ticker: CRTG), a resource for investors and traders seeking the latest updates and insights on Coretec Group stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Coretec Group's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Coretec Group's position in the market.
The Coretec Group, Inc. (OTCQB:CRTG) has appointed Allison Gabrys as its new Chief Marketing Officer. Gabrys, who has extensive marketing experience in high-tech sectors, previously led Brunswick's creative agency on the West Coast. CEO Michael Kraft expressed confidence in Gabrys's ability to enhance the company's marketing strategy, especially for its Cyclohexasilane (CHS) and CSpace technologies. This strategic hire aims to strengthen Coretec's presence and communication with investors and partners in its energy-focused verticals.
The Coretec Group (OTCQB:CRTG) announced significant progress in its commercialization of Cyclohexasilane (CHS), with physical products expected for pilot testing by early 2021. The company has confirmed a supply partnership with Evonik, which is on track to deliver samples by January 2021. Interest from customers in core markets like semiconductors and EV batteries is growing, exemplified by the partnership with Theion to develop advanced battery technology. Additionally, Coretec is now trading on the OTCQB market, enhancing visibility for investors.
The Coretec Group (OTCQB:CRTG) has successfully returned to the OTCQB Venture Market, marking a significant milestone since its merger with 3DIcon. Effective October 29, 2020, this transition reflects the company's commitment to transparent financial reporting and compliance with SEC regulations. The OTCQB offers enhanced visibility and accessibility for investors, facilitating trading through a network of broker-dealers. CEO Michael Kraft emphasized that this move strengthens the company's market presence without requiring additional actions from existing shareholders.
The Coretec Group, Inc. (OTC Pink: CRTG) has formed a strategic partnership with Theion, a Berlin-based battery technology company. This collaboration focuses on utilizing Coretec's Cyclohexasilane (CHS) technology in Theion's next-generation Quasi Solid-State Batteries (QSSB). These batteries promise superior performance, including faster charging, greater capacity, and enhanced lifespan. Coretec will act as both a development partner and key material supplier, furthering its goal to innovate silicon-based materials for energy applications. This partnership is a significant advancement in Coretec's strategy to lead in battery technology.